Related Experiment Video
Updated: Aug 7, 2025
07:58
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
567
Post hoc depression analysis from a pharmacist-led diabetes trial.
M Thomas Bateman1, Caitlin McCarthy2, Katherine M Prioli3
1Clinical Assistant Professor, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey; and Lead Clinical Pharmacist, Henry J. Austin Health Center, Trenton, New Jersey, mtb163@pharmacy.rutgers.edu.
The Mental Health Clinician
|March 9, 2023
Summary
Clinical pharmacists improved glycemic control in patients with type 2 diabetes and depression. This study highlights the benefit of pharmacist management for comorbid diabetes and depression.
Area of Science:
- Endocrinology
- Pharmacology
- Psychiatry
Background:
- Diabetes and depression frequently coexist, impacting patient outcomes.
- Clinical pharmacists are adept at managing complex chronic conditions like diabetes and depression.
- Federally Qualified Health Centers serve vulnerable populations requiring integrated care.
Purpose of the Study:
- To evaluate the impact of clinical pharmacist management on glycemic control and depressive symptoms in patients with type 2 diabetes and comorbid depression.
- To compare outcomes between patients receiving standard care versus additional management from clinical pharmacists.
Main Methods:
- Post hoc subgroup analysis of a randomized controlled trial involving patients with type 2 diabetes mellitus (T2DM) and A1C > 8%.
- Patients were randomized to either primary care provider management alone or with additional pharmacist care.
- Pharmacists conducted comprehensive medication management, tracking glycemic and depressive outcomes.
Main Results:
- Patients with depressive symptoms receiving pharmacist care showed a significant A1C reduction of -2.4 percentage points compared to -0.1 in the control group (P=.0081).
- No significant change in depressive symptoms was observed in either group.
- Pharmacist management led to increased therapeutic interventions.
Conclusions:
- Additional management by clinical pharmacists significantly improved glycemic control in patients with T2DM and comorbid depression.
- Pharmacist-led interventions enhance patient engagement and optimize pharmacotherapy for complex conditions.
- Integrating clinical pharmacists into primary care settings can improve outcomes for patients with diabetes and depression.
Related Concept Videos
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:19Pharmacovigilance
933
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
933
01:15Diabetes: Management and Pharmacotherapy
323
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
323
02:07Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
01:25Antidepressant Drugs: Overview
656
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
656
01:05Long-term Depression
31.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.2K